Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Context: Diagnosis of subclinical adrenal hypercortisolism is based on several tests of the hypothalamic-pituitary-adrenal axis to establish mild alterations of cortisol secretion and dysregulated cortisol physiology. Objective: We assessed whether plasma steroid profiles might assist diagnosis of subclinical Cushing syndrome (SC). Design: Retrospective cross-sectional study. Setting: Two tertiary medical centers. Patients: Of 208 patients tested for hypercortisolism, disease was excluded in 152 and confirmed in 21 with overt adrenal Cushing syndrome (AC) compared to 35 with SC. Another 277 age- and sex-matched hypertensive and normotensive volunteers were included for reference. Main Outcome Measures: A panel of 15 plasma steroids was measured by mass spectrometry, with classification by discriminant analysis. Results: Patients with SC had lower plasma concentrations of dehydroepiandrosterone and dehydroepiandrosterone-sulfate than subjects without SC (P < 0.05). The largest increases (P < 0.001) in plasma steroids among patients with SC were observed for 11-deoxycortisol and 11-deoxycorticosterone. Nevertheless, concentrations of 11-deoxycorticosterone, 11-deoxycortisol, and pregnenolone in patients with AC were higher (P < 0.05) than in those with SC. Patients with SC or AC could be distinguished from subjects without disease using this combination of steroids as precisely as with use of measurements of serum cortisol after administration of dexamethasone. The steroid combination provided superior diagnostic performance compared with each of the other routine biochemical tests. Conclusion: Distinct plasma steroid profiles in patients with SC may provide a simple and reliable screening method for establishing the diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1565 · Cited by 458
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas
Debono, M., Bradburn, M., Bull, M., Harrison, B., Ross, R. J., & Newell-Price, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3007 · Cited by 269
Gender-Related Differences in the Presentation and Course of Cushing’s Disease
Giraldi, F. P., Moro, M., & Cavagnini, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021518 · Cited by 260
Long-term follow-up in adrenal incidentalomas: an Italian multicenter study
Morelli, V., Reimondo, G., Giordano, R., Della Casa, S., Policola, C., Palmieri, S., Salcuni, A. S., Dolci, A., Mendola, M., Arosio, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3527 · Cited by 223
Peitzsch, M., Dekkers, T., Haase, M., Sweep, F. C. G. J., Quack, I., Antoch, G., Siegert, G., Lenders, J. W. M., Deinum, J., Willenberg, H. S., et al. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.10.006 · Cited by 169
Self-citationNunes, M.-L., Vattaut, S., Corcuff, J.-B., Rault, A., Loiseau, H., Gatta, B., Valli, N., Letenneur, L., & Tabarin, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1542 · Cited by 129
Di Dalmazi, G., Fanelli, F., Mezzullo, M., Casadio, E., Rinaldi, E., Garelli, S., Giampalma, E., Mosconi, C., Golfieri, R., Vicennati, V., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1992 · Cited by 82
Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73
Research works printed but not linked: 28
- Debono, 2015, Subclinical hypercortisolism in adrenal incidentaloma, Curr Opin Endocrinol Diabetes Obes, 22, 185, 10.1097/MED.0000000000000151 · DOI · Paper page
- Di Dalmazi, 2015, Subclinical hypercortisolism: a state, a syndrome, or a disease, Eur J Endocrinol, 173, M61, 10.1530/EJE-15-0272 · DOI · Paper page
- Nieman, 2015, Update on subclinical Cushing’s syndrome, Curr Opin Endocrinol Diabetes Obes, 22, 180, 10.1097/MED.0000000000000159 · DOI · Paper page
- Akaza, 2011, Clinical outcome of subclinical Cushing’s syndrome after surgical and conservative treatment, Hypertens Res, 34, 1111, 10.1038/hr.2011.90 · DOI
- Di Dalmazi, 2015, Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes, Curr Opin Endocrinol Diabetes Obes, 22, 163, 10.1097/MED.0000000000000153 · DOI
- Doi, 2008, Late-night salivary cortisol as a screening test for the diagnosis of Cushing’s syndrome in Japan, Endocr J, 55, 121, 10.1507/endocrj.K07E-023 · DOI · Paper page
- Gagliardi, 2010, Subclinical Cushing’s syndrome in adrenal incidentaloma: a common problem or an artefact of current diagnostic testing, Clin Endocrinol (Oxf), 72, 277, 10.1111/j.1365-2265.2009.03616.x · DOI
- Eisenhofer, 2018, Plasma steroid metabolome profiling for diagnosis and subtyping patients with Cushing syndrome, Clin Chem, 64, 586, 10.1373/clinchem.2017.282582 · DOI · Paper page
- Kotłowska, 2017, Metabolomic biomarkers in urine of Cushing’s syndrome patients, Int J Mol Sci, 18, E294, 10.3390/ijms18020294 · DOI · Paper page
- Kikuchi, 2000, Urinary steroid profile in adrenocortical tumors, Biomed Pharmacother, 54, 194s, 10.1016/S0753-3322(00)80043-8 · DOI
- Shackleton, 2010, Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis, J Steroid Biochem Mol Biol, 121, 481, 10.1016/j.jsbmb.2010.02.017 · DOI · Paper page
- Wooding, 2013, Mass spectrometry theory and application to adrenal diseases, Mol Cell Endocrinol, 371, 201, 10.1016/j.mce.2012.12.026 · DOI · Paper page
- Wilkes, 2018, Using machine learning to aid the interpretation of urine steroid profiles, Clin Chem, 64, 1586, 10.1373/clinchem.2018.292201 · DOI · Paper page
- Eisenhofer, 2017, Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS/MS: Impact of gender, age, oral contraceptives, body mass index and blood pressure status, Clin Chim Acta, 470, 115, 10.1016/j.cca.2017.05.002 · DOI · Paper page
- Meyer, 2018, Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism, Hypertension, 72, 650, 10.1161/HYPERTENSIONAHA.118.11465 · DOI
- Eisenhofer, 2016, Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism, Clin Chem, 62, 514, 10.1373/clinchem.2015.251199 · DOI · Paper page
- Williams, 2016, Genotype-specific steroid profiles associated with aldosterone-producing adenomas, Hypertension, 67, 139, 10.1161/HYPERTENSIONAHA.115.06186 · DOI · Paper page
- Stewart, 2010, Is subclinical Cushing’s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined, J Clin Endocrinol Metab, 95, 2618, 10.1210/jc.2010-0633 · DOI · Paper page
- Di Dalmazi, 2014, Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study, Lancet Diabetes Endocrinol, 2, 396, 10.1016/S2213-8587(13)70211-0 · DOI · Paper page
- Boizel, 1986, Pattern of plasma levels of cortisol, dehydroepiandrosterone and pregnenolone sulphate in normal subjects and in patients with homozygous familial hypercholesterolaemia during ACTH infusion, Clin Endocrinol (Oxf), 25, 363, 10.1111/j.1365-2265.1986.tb01702.x · DOI
- El Asmar, 2018, The value of perioperative levels of ACTH, DHEA, and DHEA-S and tumor size in predicting recurrence of Cushing disease, J Clin Endocrinol Metab, 103, 477, 10.1210/jc.2017-01797 · DOI
- Francucci, 2008, Adrenal incidentaloma: effects on bone metabolism, J Endocrinol Invest, 31, 48
- Yener, 2015, DHEAS for the prediction of subclinical Cushing’s syndrome: perplexing or advantageous, Endocrine, 48, 669, 10.1007/s12020-014-0387-7 · DOI
- Morio, 1996, Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing’s syndrome and non-functional adrenal tumor, Endocr J, 43, 387, 10.1507/endocrj.43.387 · DOI
- Yamaji, 1984, Serum dehydroepiandrosterone sulfate in Cushing’s syndrome, J Clin Endocrinol Metab, 59, 1164, 10.1210/jcem-59-6-1164 · DOI · Paper page
- Lee, 2008, A case of Cushing’s syndrome presenting as endometrial hyperplasia, Korean J Intern Med (Korean Assoc Intern Med), 23, 49
- McKenna, 1977, Plasma pregnenolone and 17-OH-pregnenolone in patients with adrenal tumors, ACTH excess, or idiopathic hirsutism, J Clin Endocrinol Metab, 44, 231, 10.1210/jcem-44-2-231 · DOI
- Haan, 2017, Patient-specific workup of adrenal incidentalomas, Eur J Radiol Open, 4, 108, 10.1016/j.ejro.2017.08.002 · DOI
Cited by
Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients
Rubinstein, G., Osswald, A., Hoster, E., Losa, M., Elenkova, A., Zacharieva, S., Machado, M. C., Hanzu, F. A., Zopp, S., Ritzel, K., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz136 · Cited by 180
Self-citationCortisol measurements in Cushing’s syndrome: immunoassay or mass spectrometry?
Casals, G., & Hanzu, F. A. (2020) · Annals of Laboratory Medicine · doi:10.3343/alm.2020.40.4.285 · Cited by 80
Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa107 · Cited by 36
“This is not surprising, since most studies have found that LNSC (regardless of assay method) has a poor sensitivity in patients with mild cortisol excess (formerly known as subclinical CS) [20, 56, 62-76].”
Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses
Yozamp, N., & Vaidya, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101491 · Cited by 33
Metadata
- Authors
- Masjkur, J., Gruber, M., Peitzsch, M., Kaden, D., Di Dalmazi, G., Bidlingmaier, M., Zopp, S., Langton, K., Fazel, J., Beuschlein, F., Bornstein, S. R., Reincke, M., & Eisenhofer, G.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2019-04-12
- Volume
- 104
- Issue
- 10
- Pages
- 4331-4340
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2937853280
- Cited by
- 51
- References
- 12
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- Else Kröner-Fresenius-Stiftung (2015_A228, 2012_A103)
- H2020 European Research Council (694913)
- Deutsche Forschungsgemeinschaft (CRC/TRR 205)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome. https://app.cochat.ai/papers/10.1210/jc.2018-02349
- The paper
- Masjkur, J., Gruber, M., Peitzsch, M., Kaden, D., Di Dalmazi, G., Bidlingmaier, M., Zopp, S., Langton, K., Fazel, J., Beuschlein, F., Bornstein, S. R., Reincke, M., & Eisenhofer, G. (2019). Plasma Steroid Profiles in Subclinical Compared With Overt Adrenal Cushing Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2018-02349
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.